A leader in nuclear technology obtains funding to produce medical isotopes in Europe and to help meet growing demands to provide diagnostic imaging for life-threatening diseases on a global scale.
Founder and CEO Greg Piefer has received the University of Wisconsin-Madison Department of Physics’ 2019 Distinguished Alumni Award. The award is the highest honor presented to accomplished graduates of UW-Madison for their professional achievements, contributions to society and support of the university.
SHINE Medical Technologies LLC today announced that its team for the annual Bert Blain Memorial Heart Walk in Janesville last weekend exceeded its fundraising goal by 40 percent. The SHINE team’s goal was $6,000 and it raised more than $8,400 to support the American Heart Association’s mission of reducing disability and death caused by heart disease and stroke.
SHINE Medical Technologies, LLC today announced the appointment of Paul D. Ryan to the company’s board of directors.
SHINE and Phoenix tested the first production-ready accelerator in SHINE’s Janesville facility over the course of 5.5 days to determine percentage uptime and total neutron output. The average system neutron yield was measured to be 10% percent beyond the required output, with greater than 99 percent uptime.
SHINE announced today that it will grant the Boys & Girls Club of Janesville $5,000 for its new STEM Lab. This grant for the Club’s STEM Lab will allow the kids to experience valuable hands-on learning in science, technology, engineering and math (STEM) – a major focus of SHINE’s Community Engagement efforts.
SHINE was proud to sponsor and participate in the 2018 Bert Blain Memorial Heart Walk in Janesville, WI. Held on August 26th, the walk supported the American Heart Association’s mission to reduce disability and death caused by cardiovascular disease and stroke. SHINE raised more than double its fundraising goal, and this year is proud to have exceeded its goal for the second year in a row, raising $4,333.
After breaking ground in August of 2017, JP Cullen completed the 6-month construction project three weeks ahead of schedule and on budget, with zero OSHA-recordable incidents. The 11,400 sq. ft. Building One will be one of the most advanced, private, nuclear technology facilities in the world.
February 13th, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Gregory Smith will join its Board of Directors. The appointment comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly‑99) and other medical isotopes.
December 12, 2016 - SHINE Medical Technologies announced today that it has been awarded $10 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $20.9 million cooperative agreement.